Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation

Annals of Thoracic Surgery

Volumn 63, Issue 4, 1997, Pages 1095-1100

  Gamel, Ahmed El ^a   Yonan, Nizar A ^a   Keevil, Brian ^a   Warbuton, Raymond ^a   Kakadellis, John ^a   Woodcock, Ashley ^a   Campbell, Colin S ^a   Rahman, Ali N ^a   Deiraniya, Abdul K ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART DENERVATION; HEART PERFORMANCE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL FACTORS; BLOOD PRESSURE; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED;

EID: 0030939377     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00168-9     Document Type: Article

References (30)

1. Cerra MC. Cardiac distribution of the binding sites for natriuretic peptides in vertebrates. Cardioscience 1994;5: 215-24.
2. Zuber M, Kiowski W, Huser B, et al. Atrial natriuretic peptide release and volume regulation following kidney transplantation. Clin Nephrol 1993;40:91-5.
3. Choy AM, Darbar D, Lang CC, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 1994;72:16-22.
4. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 1993;341:1109-13.
5. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
6. Mertes PM, de Talance N, Pinelli G, et al. Atrial natriuretic factor after heart-lung transplantation. Consequences of cardiac denervation. Presse Med 1991;20:2055-7.
7. Singer DR, Buckley MG, Macgregor GA, Khaghani A, Banner NR, Yacoub MH. Raised concentration of plasma atrial natriuretic peptides in cardiac transplant recipients. Br Med J 1986;293:1391-2.
8. El Gamel A, Yonan NA, Rahman AN, et al. Alternative heart transplantation technique [Letter]. Ann Thorac Surg 1995;59: 258-60.
9. Ationu A, Burch M, Singer D, Littleton P, Carter N. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res 1993;27:188-91.
10. Braith RW, Wood CE, Limacher MC, et al. Abnormal neuroendocrine responses during exercise in heart transplant recipients. Circulation 1992;86:1453-63.
11. Haug C, Metzele A, Kochs M, Hombach V, Grunert A. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol 1993;16:553-7.
12. Schumann G, Petersen D, Hoyer PF, Wonigeit K. Monitoring cyclosporin A (ciclosporin, INN) concentrations in whole blood: evaluation of the EMIT assay in comparison with HPLC and RIA. Eur J Clin Chem Clin Biochem 1993;31: 381-8.
13. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9:587-93.
14. Portaluppi F, Vergnani L, degli Uberti EC. Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach. Chronobiol Int 1993;10:176-89.
15. Gozdzik J. Control of the quality of radioimmunological methods of determining plasma levels of atrial natriuretic peptide (ANP) and the evaluation of their usefulness in clinical studies. Ann Acad Med Stetin 1992;38:125-39.
16. Wei CM, Heublein DM, Perrella MA, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88: 1004-9.
17. Sakai T, Latson TW, Whitten CW, et al. Changes in plasma atrial natriuretic peptide concentration during heart transplantation. J Cardiothorac Vasc Anesth 1992;6:686-91.
18. Kato H, Yasue H, Yoshimura M, et al. Suppression of hyperventilation-induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina. Am Heart J 1994;128(6 Pt 1):1098-104.
19. Pidgeon GB, Richards AM, Nicholls MG, et al. Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension. Hypertension 1996;27: 906-13.
20. Nakao K, Imura H. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9.
21. Kalaycioglu S, Soncul H, Halit V, et al. Effect of right atrial appendicectomy on the release of atrial natriuretic peptide in humans. Cardiovasc Surg 1993;1:426-31.
22. De Vries PJ, Tyssen CM, Struyker Boudier HA, Smits JF. Physiological role of ANP under resting and volume expanded conditions in normotensive rats. Life Sci 1990;47: 2291-7.
23. Schwietzer GK, Hartmann A, Kober G, et al. Chronic angiotensin-converting enzyme inhibition may improve sodium excretion in cardiac transplant hypertension. Transplantation 1995;59:999-1004.
24. Schuler S, Thomas D, Hetzer R. Cyclosporine A-related nephrotoxicity after cardiac transplantation: the role of plasma renin activity. Transplant Proc 1987;19:3998-4001.
25. Capasso G, Rosati C, Ciani F, et al. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Am J Hypertens 1990;3:204-10.
26. Jahnke AW, Rainer L, Bernhard A, Sievers HH. Atrial natriuretic peptide release at rest and with exercise after cardiac transplantation with bicaval anastomoses. J Thorac Cardiovasc Surg 1995;110:1600-5.
27. Ationu A, Sorensen K, Whitehead B, et al. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children - a three year follow up. Cardiovasc Res 1993;27:2135-9.
28. Arbustini E, Pucci A, Grasso M, et al. Expression of natriuretic peptide in ventricular myocardium of failing human hearts and its correlation with the severity of clinical and hemodynamic impairment. Am J Cardiol 1990;66:973-80.
29. Gu J, D'Andrea M, Seethapathy M, McDonnell C, Cichon R. Physical overdistension converts ventricular cardiomyocytes to acquire endocrine property and regulate ventricular atrial natriuretic peptide production. Angiology 1991;42:173-86.
30. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995;98:257-65.